Producer
Northeast Pharmaceutical Group Co., Ltd. (NEPG)
One of China's largest bulk vitamin C (ascorbic acid) fermentation producers; named defendant in the US vitamin C antitrust litigation.
2
Inputs supplied
4
Goods downstream
1
Facilities
0
Stories
What they make
2 inputs Northeast Pharmaceutical Group Co., Ltd. (NEPG) supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Northeast Pharmaceutical Group Co., Ltd. (NEPG) makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Vitamin C & Derivatives
60%Other Vitamins & APIs
25%Chemical Products
10%Animal Nutrition
5%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Origin2016
NEPG (Northeast Pharmaceutical Group) was one of four Chinese vitamin C producers named in In re Vitamin C Antitrust Litigation (E.D.N.Y., 2005), one of the most significant international antitrust cases of the 2000s. The case alleged that NEPG, CSPC, DSM Jiangshan, and WeiFang Ensign coordinated vitamin C prices and export quantities at the direction of the Chinese Chamber of Commerce for the Import and Export of Medicines. The 4th Circuit vacated a million jury verdict in 2016 on foreign sovereign compulsion grounds, but the case was remanded (2019) and continued. The litigation established precedent that Chinese government cartel behavior could shield private companies from US antitrust exposure.
U.S. Department of Justice ↗Did you know2024
NEPG's bulk ascorbic acid — the vitamin C sold in dietary supplements — is the same molecule used as a cosmetic active in Vitamin C serums, spot-brightening creams, and anti-aging formulas. Ingredient companies (DSM, BASF, Givaudan Active Beauty) take NEPG bulk and convert it into stabilized derivatives (MAP, AA2G, ascorbyl glucoside) for the B+ global Vitamin C cosmetics market. China's ~85% share of global bulk ascorbic acid supply means cosmetic formulators in the US and EU are exposed to Chinese supply chain risk even for premium skincare products — a connection rarely surfaced in cosmetic supply-chain reviews.
Mordor Intelligence ↗Concentration2024
China's Big Four vitamin C producers (NEPG, CSPC, DSM Jiangshan, and WeiFang Ensign) collectively produce approximately 85% of global bulk ascorbic acid. Total global supply is ~400,000 metric tons/year; China produces ~340,000 t/yr. Despite decades of attempted diversification, no Western bulk producer has re-entered the market since DSM shut its European fermentation lines in 2014. NEPG alone has capacity of approximately 60,000–80,000 t/yr. A coordinated Chinese export restriction or single large-plant outage in Shenyang would immediately affect global vitamin supplement, food fortification, and cosmetic ingredient supply.
IndexBox ↗